Nethertone Syndrome Market: Analysis of Epidemiology, Therapies in Pipeline and Key Companies Working in the Market

[ad_1]

DelveInsight Business Research LLP

The Netherton Syndrome Market Insights, Epidemiology, and Market Forecast-2032 report from DelveInsight offers an in-depth understanding of Netherton Syndrome, historical and forecasted epidemiology as well as Netherton Syndrome market trends in the United States, in the EU5 (Germany, Spain, Italy, France and the United Kingdom) and in Japan.

by DelveInsight Netherton Syndrome Market Overview, Epidemiology and Market Forecast-2032″ The report provides an in-depth understanding of Netherton Syndrome, historical and forecast epidemiology as well as Netherton Syndrome market trends in the US, EU5 (Germany, Spain, Italy, France and UK) and in Japan.

Netherton Syndrome Market report provides current treatment practices, emerging drugs, Netherton Syndrome market share of individual therapies, current and forecast Netherton Syndrome market size from 2019 to 2032 segmented by seven main markets. The report also covers current Netherton Syndrome treatment practices/algorithms, market drivers, market barriers and unmet medical needs to select the best opportunities and assesses the underlying potential of the Netherton Syndrome market.

Some of the Key Facts of the Netherthone Syndrome Market Report:

  • In the United States, severe cases of Netherton syndrome were estimated at 184 cases in 2020 and are expected to increase during the 2018-2030 study period.

  • The incidence and prevalence of NS have been estimated at 1/200,000 births and 1-9/million, respectively; similar figures are published in most available publications around the world. Moreover, it has been reported that this NS could account for up to 18% of congenital erythroderma (Orphanet, 2021).

Key Benefits of Netherthon Syndrome Report:

  • The report covers the descriptive overview of Netherton syndrome, explaining its causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies.

  • A comprehensive overview was provided on the epidemiology and treatment of Netherton syndrome in 7MM

  • Additionally, a comprehensive account of current and emerging therapies for Netherton syndrome is provided, along with the assessment of new therapies, which will impact the current treatment landscape.

  • A detailed review of the Netherton Syndrome Market; historical and forecast is included in the report, covering drug awareness in the 7MM

  • The report provides an edge when developing business strategies, by understanding the trends shaping and driving the global Netherton Syndrome market

You have questions ? Click here to learn more about the Netherthon Syndrome market landscape

Overview of Netherton Syndrome

Netherton syndrome (NS) is a rare autosomal recessive syndromic ichthyosis caused by mutations in the SPINK5 gene, which codes for the lymphoepithelial protein Kazal-type-related inhibit (LEKTI). The exact incidence of NS is unknown, in part because it is difficult to diagnose. .

With approximately 150 cases reported in the scientific literature, it is estimated that approximately 1/200,000 people worldwide have NS. Symptoms are present at birth and include red, scaly skin. Other symptoms include circular, scaly red rashes, thin, brittle hair (bamboo hair), and immune reactions such as hay fever, asthma, itchy skin, and eczema. Dehydration and infection are common and can be serious. Babies tend to grow slowly and gain little weight. NS is diagnosed based on symptoms and confirmed by genetic testing for changes in the SPINK5 gene. Other types of tests, such as a careful hair examination and a skin biopsy to get a small sample of skin to look at under a microscope, can also be helpful in diagnosis. Neonatal period disease should be distinguished from several other disorders with extensive squamous erythroderma, growth retardation, and increased risk of infection, in particular several immunodeficiency disorders, other ichthyosis, and atopic or psoriasiform erythroderma.

Epidemiological overview of Netherthone syndrome:

  • According to the National Organization for Rare Disorders (NORD) (nd), NS is a rare inherited condition with approximately 150 cases reported in the medical literature. However, the actual number of affected individuals may be much higher due to diagnostic difficulties and overlapping symptoms with common atopic dermatitis and other congenital ichthyosis.

  • According to DelveInsight’s assessment, in 2020 the prevalent cases of Netherton syndrome in the United States were 1,658, which is expected to increase.

Netherton Syndrome Market Outlook

The Netherton Syndrome Market outlook of the report helps to construct a detailed understanding of the historical, current and forecast Netherton Syndrome Market trends by analyzing the impact of current Netherton Syndrome Therapies on the market, unmet needs, drivers and barriers; and the demand for better technology.

This segment gives a comprehensive detail of Netherton Syndrome market trend for each marketed drug and late-stage pipeline therapy by rating their impact based on annual therapy cost, inclusion and exclusion criteria, mechanism of action, compliance rate, growing market need, increasing number of patients, patient segment covered, expected year of launch, competition with other therapies, brand value , their impact on the market and the opinion of key opinion leaders. The calculated Netherton Syndrome market data is presented with relevant tables and graphs to give a clear view of the market at first glance.

According to DelveInsight, the 7MM Netherton Syndrome market is expected to witness a major shift during the study period 2019-2032.

Learn More By Requesting A Sample @ Netherthone Syndrome Market Trends

Netherton Syndrome Key Societies

  • Lifemax Laboratories

  • AnaptysBio

  • Jassen Biotech

  • And much more

Netherton Syndrome Therapies

  • LM-030

  • Imsidolimab

  • Ustekinumab

  • And much more

Contents

  • key ideas

  • Presentation of the report

  • Netherthone Syndrome Executive Summary

  • Background and overview of the disease

  • Epidemiology and patient population

  • Emerging Therapies of Netherthone Syndrome

  • Netherthon Syndrome Market Outlook

  • Market access and reimbursement of therapies

  • Annex

  • Netherthon Syndrome Report Methodology

  • Features of DelveInsight

  • Disclaimer

  • About DelveInsight

Click here to read more about Netherthon Syndrome Market Overview

Media Contact
Company Name: DelveInsight Business Research LLP
Contact person: Adya Kaoul
E-mail: Send an email
Call: 9193216187
Address:304 S. Jones Boulevard #2432
Town: Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

[ad_2]
Source link

Comments are closed.